SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-18-000564
Filing Date
2018-12-20
Accepted
2018-12-19 17:31:14
Documents
1
Group Members
DAVID M. MOTTFOREST BASKETTNEA 13 GP, LTDNEA PARTNERS 13, L.P.PATRICK J. KERINSPETER J. BARRISSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 13, L.P. - RA PHARMACEUTICALS, INC. -- SCHEDULE 13D/A rapharma13da2_18275.htm SC 13D/A 294184
  Complete submission text file 0001072613-18-000564.txt   295837
Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 410-244-0115
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by) CIK: 0001452907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A

Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Subject) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89680 | Film No.: 181244195
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1